Two studies have suggested that a Ki-67 labelling index of more than 20% was associated with a significantly worse locoregional control (56%) in oropharyngeal cancer (Grabenbauer et al, 2000; Wilson et al, 2006). This evidence concerns the gene MKI67 and oropharynx cancer.